Eckert & Ziegler SE
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
25.39%
Market Cap
959.92 Mil.
P/E Ratio
19.58
Dividend Yield
1.44 %
Earnings per Share
0.78 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 15.34 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:55:43 PM | |
| DAILY VOLUME (UNITS) | 4,336 | |
| DAILY HIGH / LOW | 15.5 | 15.09 |
| PREV. DAY'S PRICE | 15.47 | (06/02) |
| CHANGE DAY BEFORE | -0.13 | -0.84 % |
| 52 WEEK HIGH / LOW | 23 (07/17) | 13.41 (03/23) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 0.90 | 0.84 | 0.78 | 0.53 | 0.42 |
| DIVIDENDS PER SHARE | 0.28 | 0.25 | 0.22 | 0.17 | 0.02 |
| DIVIDEND YIELD IN % | - | - | 1.44 % | 1.12 % | 0.12 % |
| DIVIDEND GROWTH IN % | - | - | 32.00 % | 899.82 % | -90.00 % |
| PRICE - EARNINGS RATIO | 18.36 | 19.67 | 19.58 | 27.88 | 32.68 |
| PRICE - BOOK RATIO | - | - | 3.79 | 4.15 | 3.87 |
| PRICE - SALES RATIO | - | - | 3.07 | 3.14 | 3.49 |
| PRICE - CASH FLOW RATIO | - | - | 15.86 | 13.76 | 18.32 |
Master Data
| WKN | 565970 |
| ISIN | DE0005659700 |
| SYMBOL | EUZ |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Eckert+Ziegler |
| INDEX MEMBERSHIP | TecDAX, SDAX |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 62.58 Mil. |
| MARKET CAPITALISATION | 959.92 Mil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.52 % | 2.25 % | 2.86 % | -0.90 % | -25.39 % | 13.97 % | -48.60 % | 1.71 % |
| HIGH | 16.81 | 16.81 | 16.81 | 16.81 | 23.00 | 23.00 | 47.10 | 16.81 |
| LOW | 15.40 | 14.06 | 13.41 | 13.41 | 13.41 | 9.67 | 9.67 | 13.41 |
Dividend
per share
Company profile
Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.
Structured products for Eckert & Ziegler SE
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
(in 21 days)
06/24/26Annual General Meeting
(in 64 days)
08/06/26Q2 2026 Earnings Release
(in 110 days)
09/21/26Berenberg and Goldman Sachs German Corporate Conference
(in 119 days)
09/30/26NuWays MidCap Conference
(in 167 days)
11/17/26Q3 2026 Earnings Release